After the typical end of summer slowdown around the Labor Day Holiday, two healthcare companies plan their IPO debut tomorrow:
Affimed Therapeutics B.V. (AFMD:NSDQ) is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. The company is offering 6.25M shares (all primary) @ $11.00-13.00. Jefferies & Company, Leerink Partners, and BMO Capital Markets are acting as lead managers, with Trout Capital as a co-manager. Proceeds are expected to be used to fund research and development expenses for their clinical stage candidates AFM13, and AFM11, as well as their pre-clinical candidate AFM21.
ReWalk Robotics Ltd. (RWLK:NSDQ) is a medical device company that is designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The company is offering 3.35M shares (all primary) @ $14.00-16.00. Barclays Capital and Jefferies & Company are acting as lead managers, with Canaccord Genuity as a co-manager. The company received FDA clearance in June 2014, and CE Mark clearance for both personal and rehabilitation use. Proceeds are expected to be used for general corporate purposes, including sales and marketing and research and development expenditures.
The U.S.IPO market is expected to pick up steam next week with an expected 7 new offerings, including the highly anticipated offering of Alibaba (BABA:NYSE) at the end of the week.
Posted in IPO
Tagged AFMD, RWLK
Facebook (FB) may be getting most of the headlines and attention, but another social media company has not been lost on the institutional investors. Yelp Inc. (YELP) opened Friday morning at $22.01, after pricing their 7.15 million share IPO at $15.00, above the indicated range of $12-14. The majority of the shares, 7.1 million, are being sold by the company, with the additional 50,000 shares being sold by the selling shareholder, The Yelp Foundation. Based on the $15.00 pricing, the company will have a market capitalization of approximately $898 million. Goldman Sachs, Citigroup, and Jefferies are leading the offering. Bessemer Venture Partners, Elevation Partners, and Benchmark Capital are not selling on the offering and will own approximately 22%, 22% and 16% respectively post offering.
For full article: http://seekingalpha.com/article/407831-not-all-investors-are-waiting-for-facebook-yelp-ipo-opens-up-over-46?v=1330707171&source=tracking_notify
EPAM Systems, Inc. (EPAM) opened up 14.5% at $13.75 Wednesday morning, after pricing a downsized 6 million share IPO at $12.00, versus filing range of $16-$18 on 7.4 million shares. Only about 1.52 million shares (per the last SEC filing of the 7.4 million shares) are coming from the company, while the remaining shares are offered by selling shareholders. Based on the $12.00 pricing, the company will have a market capitalization of approximately $488 million. Citigroup (C), UBS, Barclays (BCS), and RenCap are leading the offering.
For full article: http://seekingalpha.com/article/351061-epam-systems-ipo-priced-to-work-at-12-00
Posted in IPO
Tagged CTSH, EPAM, IGTE, INFY, SYNT, VIT, WIT
Five and a half months after filing their S-1 with the SEC, Zynga Inc. (ZNGA) will finally make their public debut on the Nasdaq Friday morning. The company priced their 100 million share IPO at $10.00, the high end the indicated range of $8.50-10.00. All of the shares are being offered by the company, which intends to use the proceeds for general corporate purposes, including working capital, game development, marketing and capital expenditures. Based on the $10.00 pricing, the company will have a market capitalization of approximately $6.99 billion (closer to about $8.5-$9 billion on a fully diluted basis when including stock options, restricted stock units and warrants).Morgan Stanley and Goldman Sachs are leading the offering.
For full article: http://seekingalpha.com/article/314327-after-much-anticipation-zynga-ipo-prices-at-10-00
Posted in Uncategorized
Michael Kors Holdings Ltd. (KORS) opened up 25% Thursday morning, after pricing its upsized 47.2 million share IPO at $20.00, above the indicated range of $17.00-19.00. Based on the $20.00 pricing, the company will have a market capitalization of approximately $3.82 billion. Morgan Stanley, J.P. Morgan and Goldman Sachs are leading the offering.
For full article: http://seekingalpha.com/article/314142-michael-kors-ipo-opens-up-25-on-strong-demand
Posted in IPO
With 12 U.S. listed IPOs scheduled to price this week, it will be the most active week not only of 2011, but since 2007. While the anticipated pricings later this week of Zynga Inc. (ZYNG) and Michael Kors Holdings (KORS) catching all the headlines, the first to come out this week Jive Software, Inc. (JIVE) opened up 26% at $15.12 Tuesday morning on the Nasdaq.
For full article: http://seekingalpha.com/article/313613-jive-software-starts-a-busy-ipo-week-off-with-a-bang
Posted in Uncategorized
Tagged IPO, JIVE
Rentech Nitrogen Partners LP (RNF) priced their 15 million unit IPO at $20.00, the midpoint of the indicated range of $19.00-21.00. All of the units are being offered by the company, however, a majority of the proceeds will flow back to the parent company and it subsidiaries as a capital contribution to repay debt incurred and as a distribution as reimbursement of expenditures. Based on the $20.00 pricing, the company will have a market capitalization of approximately $765 million, and an estimated forward dividend yield of 11.7%. Morgan Stanley and Credit Suisse are leading the offering.
For full article: http://seekingalpha.com/article/305177-rentech-nitrogen-ipo-entices-buyers-with-high-yield